If you google "Tamiflu" and filter by results over the "Past 24 hours", you will note that perhaps 50% of the matches (conservatively) have some reference to Tamiflu and "Resistance".
By contrast, when googling "Relenza", matches to "Resistance" only tend to pop up when the reference is being compared and related to resistance to Tamiflu.
The WHO will not be able to keep its proverbial head in the sand for much longer and despite its long term preference to Tamiflu over Relenza, it is getting very close to a point where it will be seen as negligent in its duty of care by continuing to publicly favour Tamiflu over Relenza.
Is it possible that we will see Glaxo look to further increase production real soon now?
BTA Price at posting:
$2.16 Sentiment: LT Buy Disclosure: Held
